1. Home
  2. NABL vs MDXG Comparison

NABL vs MDXG Comparison

Compare NABL & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$3.64

Market Cap

945.6M

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.61

Market Cap

530.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NABL
MDXG
Founded
2000
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
945.6M
530.2M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
NABL
MDXG
Price
$3.64
$3.61
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$8.31
$9.00
AVG Volume (30 Days)
1.3M
1.7M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
$511,430,000.00
$418,630,000.00
Revenue This Year
$11.04
N/A
Revenue Next Year
$8.53
$13.02
P/E Ratio
N/A
N/A
Revenue Growth
9.71
19.99
52 Week Low
$3.24
$3.03
52 Week High
$9.04
$7.99

Technical Indicators

Market Signals
Indicator
NABL
MDXG
Relative Strength Index (RSI) 33.73 49.42
Support Level $3.24 $3.45
Resistance Level $5.22 $7.39
Average True Range (ATR) 0.35 0.12
MACD -0.09 0.04
Stochastic Oscillator 18.04 51.43

Price Performance

Historical Comparison
NABL
MDXG

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: